Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 184

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 184
---
>

Nominating and Corporate Governance Committee.Our nominating and corporate governance committee will consist of Bin Zhou, Kenrick B Toussaint and Chun Fai Fong. Bin Zhou will be the chairperson of our nominating and corporate governance committee. The nominating and corporate governance committee will assist the board of directors in selecting individuals qualified to become our directors and in determining the composition of the board and its committees. The nominating and corporate governance committee will be responsible for, among other things:

| ● | identifying                                                                                        
 and recommending nominees for election or re-election to our board of directors or for appointment 
 to fill any vacancy;                                                                               |

| ● | reviewing                                                                                    
 annually with our board of directors its current composition in light of the characteristics 
 of independence, age, skills, experience and availability of service to us;                  |

| ● | identifying                                                                    
 and recommending to our board the directors to serve as members of committees; |

| ● | advising                                                                                    
 the board periodically with respect to significant developments in the law and practice of  
 corporate governance as well as our compliance with applicable laws and regulations, and    
 making recommendations to our board of directors on all matters of corporate governance and 
 on any corrective action to be taken; and                                                   |

| ● | monitoring                                                                                
 compliance with our code of business conduct and ethics, including reviewing the adequacy 
 and effectiveness of our procedures to ensure proper compliance.                          |

Code of Business Conduct and Ethics, Insider Trading Policy and Clawback Policy

We have adopted (i) a code of business conduct
and ethics, (ii) an insider trading policy that applies to our directors, officers, and employees, and (iii) a clawback policy that
applies to our directors, officers and employees (collectively, the “Policies”). The Policies will become effective upon the
effectiveness of the registration statement of which this prospectus is a part.

Corporate Governance

We are a “foreign private issuer,” as defined by the SEC. As a result, in accordance with the rules and regulations of Nasdaq, we may at our option comply with home country governance requirements and certain exemptions thereunder rather than complying with Nasdaq corporate governance standards. While we currently intend to voluntarily follow all Nasdaq corporate governance rules, including rules regarding committee structure and director independence, as described above, we mayin the future choose to take advantage of the following exemptions afforded to foreign private issuers:

| ● | Exemption from the requirement                                               
 that a majority of our board of directors consists of independent directors. |